Ring synthesis by stereoselective, methylene-free enyne cross metathesis.J Am Chem Soc. 2004 Jul 07; 126(26):8110-1.JA
Abstract
Tandem enyne metathesis between 1-alkynes and 1,5-cyclooctadiene or all-cis-1,4-polybutadiene resulted in a direct, one-step ring synthesis of cyclohexadienes by methylene-free metathesis. The use of methylene-free metathesis conditions provided apparent Z-selectivity in the intermolecular enyne metathesis step.
MeSH
Pub Type(s)
Journal Article
Research Support, U.S. Gov't, P.H.S.
Language
eng
PubMed ID
15225040
Citation
Kulkarni, Amol A., and Steven T. Diver. "Ring Synthesis By Stereoselective, Methylene-free Enyne Cross Metathesis." Journal of the American Chemical Society, vol. 126, no. 26, 2004, pp. 8110-1.
Kulkarni AA, Diver ST. Ring synthesis by stereoselective, methylene-free enyne cross metathesis. J Am Chem Soc. 2004;126(26):8110-1.
Kulkarni, A. A., & Diver, S. T. (2004). Ring synthesis by stereoselective, methylene-free enyne cross metathesis. Journal of the American Chemical Society, 126(26), 8110-1.
Kulkarni AA, Diver ST. Ring Synthesis By Stereoselective, Methylene-free Enyne Cross Metathesis. J Am Chem Soc. 2004 Jul 7;126(26):8110-1. PubMed PMID: 15225040.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Ring synthesis by stereoselective, methylene-free enyne cross metathesis.
AU - Kulkarni,Amol A,
AU - Diver,Steven T,
PY - 2004/7/1/pubmed
PY - 2004/10/8/medline
PY - 2004/7/1/entrez
SP - 8110
EP - 1
JF - Journal of the American Chemical Society
JO - J Am Chem Soc
VL - 126
IS - 26
N2 - Tandem enyne metathesis between 1-alkynes and 1,5-cyclooctadiene or all-cis-1,4-polybutadiene resulted in a direct, one-step ring synthesis of cyclohexadienes by methylene-free metathesis. The use of methylene-free metathesis conditions provided apparent Z-selectivity in the intermolecular enyne metathesis step.
SN - 0002-7863
UR - https://www.unboundmedicine.com/medline/citation/15225040/Ring_synthesis_by_stereoselective_methylene_free_enyne_cross_metathesis_
DB - PRIME
DP - Unbound Medicine
ER -